Table of Contents
ISRN Obstetrics and Gynecology
Volume 2011 (2011), Article ID 146264, 9 pages
http://dx.doi.org/10.5402/2011/146264
Review Article

Management of Women with Surgically Staged 1 Uterine Papillary Serous Cancer

1Department of Obstetrics and Gynecology, McMaster University, Hamilton, ON, Canada L8N 3Z5
2Department of Gynecologic Oncology, St. Augustinus Hospital, L8V 5C2 Antwerp, Belgium

Received 20 May 2011; Accepted 6 July 2011

Academic Editors: L. Gebrim, E. Petru, and L. B. Twiggs

Copyright © 2011 Laurie Elit et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Karpas and M. F. Bridge, “Endometrial adenocarcinoma with psammomatous bodies,” American Journal of Obstetrics and Gynecology, vol. 87, pp. 935–941, 1963. View at Google Scholar · View at Scopus
  2. S. C. Lauchlan, “Tubal (serous) carcinoma of the endometrium,” Archives of Pathology and Laboratory Medicine, vol. 105, no. 11, pp. 615–618, 1981. View at Google Scholar · View at Scopus
  3. M. Hendrickson, J. Ross, P. Eifel, A. Martinez, and A. Martinez, “Uterine papillary serous carcinoma. A highly malignant form of endometrial adenocarcinoma,” American Journal of Surgical Pathology, vol. 6, no. 2, pp. 93–108, 1982. View at Google Scholar
  4. M. Hendrickson, J. Ross, P. J. Eifel, R. S. Cox, A. Martinez, and R. Kempson, “Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables,” Gynecologic Oncology, vol. 13, no. 3, pp. 373–392, 1982. View at Google Scholar
  5. H. J. Spjut, R. H. Kaufman, and S. S. Carrig, “Psammoma bodies in the cervico-vaginal smear,” Acta Cytologica, vol. 8, pp. 352–355, 1964. View at Google Scholar · View at Scopus
  6. K. Hameed and D. A. Morgan, “Papillary adenocarcinoma of endometrium with psammoma bodies. Histology and fine structure,” Cancer, vol. 29, no. 5, pp. 1326–1335, 1972. View at Google Scholar · View at Scopus
  7. V. A. LiVolsi, “Adenocarcinoma of the endometrium with psammoma bodies,” Obstetrics and Gynecology, vol. 50, no. 6, pp. 725–728, 1977. View at Google Scholar · View at Scopus
  8. P. Rosenberg, R. Blom, T. Hogberg, and E. Simonsen, “Death rate and recurrence pattern among 841 clinical stage I endometrial cancer patients with special reference to uterine papillary serous carcinoma,” Gynecologic Oncology, vol. 51, no. 3, pp. 311–315, 1993. View at Publisher · View at Google Scholar
  9. P. Rosenberg, B. Risberg, L. Askmalm, and E. Simonsen, “The prognosis in early endometrial carcinoma. The importance of uterine papillary serous carcinoma (UPSC), age, FIGO grade and nuclear grade,” Acta Obstetricia et Gynecologica Scandinavica, vol. 68, no. 2, pp. 157–163, 1989. View at Google Scholar
  10. B. C. Turner, J. P.S. Knisely, B. M. Kacinski et al., “Effective treatment of Stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 40, no. 1, pp. 77–84, 1998. View at Publisher · View at Google Scholar
  11. M. E. Sherman, P. Bitterman, N. B. Rosenshein, G. Delgado, and R. J. Kurman, “Uterine serous carcinoma: a morphologically diverse neoplasm with unifying clinicopathologic features,” American Journal of Surgical Pathology, vol. 16, no. 6, pp. 600–610, 1992. View at Google Scholar · View at Scopus
  12. V. M. Abeler and K. E. Kjorstad, “Serous papillary carcinoma of the endometrium: a histopathological study of 22 cases,” Gynecologic Oncology, vol. 39, no. 3, pp. 266–271, 1990. View at Publisher · View at Google Scholar · View at Scopus
  13. B. G. Ward, R. G. Wright, and K. Free, “Papillary carcinomas of the endometrium,” Gynecologic Oncology, vol. 39, no. 3, pp. 347–351, 1990. View at Publisher · View at Google Scholar · View at Scopus
  14. J. F. Jeffrey, G. V. Krepart, and R. J. Lotocki, “Papillary serous adenocarcinoma of the endometrium,” Obstetrics and Gynecology, vol. 67, no. 5, pp. 670–674, 1986. View at Google Scholar
  15. R. P. Matthews, J. Hutchinson-Colas, M. Maiman et al., “Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women,” Gynecologic Oncology, vol. 65, no. 2, pp. 206–212, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. G. P. Sutton, L. Brill, H. Michael, F. B. Stehman, and C. E. Ehrlich, “Malignant papillary lesions of the endometrium,” Gynecologic Oncology, vol. 27, no. 3, pp. 294–304, 1987. View at Google Scholar · View at Scopus
  17. J. T. Chambers, M. Merino, and E. I. Kohorn, “Uterine papillary serous carcinoma,” Obstetrics and Gynecology, vol. 69, no. 1, pp. 109–113, 1987. View at Google Scholar
  18. M. L. Carcangiu and J. T. Chambers, “Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma,” Gynecologic Oncology, vol. 47, no. 3, pp. 298–305, 1992. View at Publisher · View at Google Scholar
  19. K. R. Lee and J. L. Belinson, “Papillary serous adenocarcinoma of the endometrium: a clinicopathologic study of 19 cases,” Gynecologic Oncology, vol. 46, no. 1, pp. 51–54, 1992. View at Publisher · View at Google Scholar · View at Scopus
  20. C. J. Dunton, G. Balsara, M. McFarland, and E. Hernandez, “Uterine papillary serous carcinoma: a review,” Obstetrical and Gynecological Survey, vol. 46, no. 2, pp. 97–102, 1991. View at Google Scholar · View at Scopus
  21. W. M. Christopherson, R. C. Alberhasky, and P. J. Connelly, “Carcinoma of the endometrium. II. Papillary adenocarcinoma: a clinical pathological study 46 cases,” American Journal of Clinical Pathology, vol. 77, no. 5, pp. 534–540, 1982. View at Google Scholar · View at Scopus
  22. H. H. Gallion, J. R. Van Nagell, D. F. Powell et al., “Stage I serous papillary carcinoma of the endometrium,” Cancer, vol. 63, no. 11, pp. 2224–2228, 1989. View at Google Scholar · View at Scopus
  23. C. E. Ramirez-Gonzalez, K. Adamsons, T. Y. Mangual-Vazquez, and R. C. Wallach, “Papillary adenocarcinoma in the endometrium,” Obstetrics and Gynecology, vol. 70, no. 2, pp. 212–215, 1987. View at Google Scholar · View at Scopus
  24. A. Goodman and B. Goff, “Endometrial cancer: screening, diagnosis and Surgical Staging,” Clinical Obstetrics and Gynecology, vol. 13, pp. 739–750, 1986. View at Google Scholar
  25. B. A. Goff, D. Kato, R. A. Schmidt et al., “Uterine papillary serous carcinoma: patterns of metastatic spread,” Gynecologic Oncology, vol. 54, no. 3, pp. 264–268, 1994. View at Publisher · View at Google Scholar · View at Scopus
  26. P. A. Gehrig, P. A. Groben, W. C. Fowler, L. A. Walton, and L. Van Le, “Noninvasive papillary serous carcinoma of the endometrium,” Obstetrics and Gynecology, vol. 97, no. 1, pp. 153–157, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. J. K. Chan, V. Loizzi, M. Youssef et al., “Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium,” Gynecologic Oncology, vol. 90, no. 1, pp. 181–185, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. R. E. Bristow, F. Asrari, E. L. Trimble, and F. J. Montz, “Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (stage 1-3) disease,” Gynecologic Oncology, vol. 81, no. 2, pp. 279–286, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. W. K. Huh, M. Powell, C. A. Leath III et al., “Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy,” Gynecologic Oncology, vol. 91, no. 3, pp. 470–475, 2003. View at Publisher · View at Google Scholar
  30. K. M. Zanotti, J. L. Belinson, A. W. Kennedy, K. D. Webster, and M. Markman, “The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma,” Gynecologic Oncology, vol. 74, no. 2, pp. 272–277, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. A. N. Walker and S. E. Mills, “Serous papillary carcinoma of the endometrium. A clinicopathologic study of 11 cases,” Diagnostic Gynecology and Obstetrics, vol. 4, no. 4, pp. 261–267, 1982. View at Google Scholar
  32. A. L. Fields, M. H. Einstein, A. P. Novetsky, J. Gebb, and G. L. Goldberg, “Pilot phase II trial of radiation “sandwiched” between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC),” Gynecologic Oncology, vol. 108, no. 1, pp. 201–206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. M. L. Carcangiu, L. K. Tan, and J. T. Chambers, “Stage 1A uterine serous carcinoma: a study of 13 cases,” American Journal of Surgical Pathology, vol. 21, no. 12, pp. 1507–1514, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. C. S. Dietrich, S. C. Modesitt, P. D. Depriest et al., “The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC),” Gynecologic Oncology, vol. 99, no. 3, pp. 557–563, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Elit, J. Kwon, J. Bentley, K. Trim, I. Ackerman, and M. Carey, “Optimal management for surgically Stage 1 serous cancer of the uterus,” Gynecologic Oncology, vol. 92, no. 1, pp. 240–246, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. A. N. Fader, D. Boruta, A. B. Olawaiye, and P. A. Gehrig, “Uterine papillary serous carcinoma: epidemiology, pathogenesis and management,” Current Opinion in Obstetrics & Gynecology, vol. 22, no. 1, pp. 21–29, 2010. View at Google Scholar · View at Scopus
  37. A. N. Fader, R. D. Drake, D. M. O’Malley et al., “Platinum/Taxane-based chemotherapy with or without radiation therapy favourably impacts survival outcomes in stage1 uterine papillary serous carcinoma,” Cancer, vol. 115, pp. 2119–2127, 2009. View at Google Scholar
  38. A. N. Fader, D. Starks, P. A. Gehrig et al., “An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC),” Gynecologic Oncology, vol. 115, no. 2, pp. 244–248, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. L. J. Havrilesky, A. Alvarez Secord, V. Bae-Jump et al., “Outcomes in surgical stage 1 uterine papillary serous carcinoma,” Gynecologic Oncology, vol. 105, pp. 677–682, 2007. View at Google Scholar
  40. M. G. Kelly, D. M. O'Malley, P. Hui et al., “Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy,” Gynecologic Oncology, vol. 98, no. 3, pp. 353–359, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. M. B. Thomas, A. Mariani, W. A. Cliby, G. A. Keeney, K. C. Podratz, and S. C. Dowdy, “Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma,” Gynecologic Oncology, vol. 107, no. 2, pp. 186–189, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Bancher-Todesca, W. Neunteufel, K. E. Williams et al., “Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma,” Gynecologic Oncology, vol. 71, no. 3, pp. 344–347, 1998. View at Publisher · View at Google Scholar
  43. J. Grice, M. Ek, B. Greer et al., “Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients,” Gynecologic Oncology, vol. 69, no. 1, pp. 69–73, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. P. A. Gehrig, “Uterine papillary serous carcinoma: a review,” Expert Opinion on Pharmacotherapy, vol. 8, no. 6, pp. 809–816, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. J. S. H. Low, E. H. Wong, H. S. K. Tan et al., “Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma,” Gynecologic Oncology, vol. 97, no. 1, pp. 171–177, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. B. Piura, M. Meirovitz, M. Shmulman, I. Yanai-Inbar, Y. Cohen, and R. Dgani, “Uterine papillary serous carcinoma: study of 19 cases,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 79, no. 1, pp. 69–73, 1998. View at Publisher · View at Google Scholar · View at Scopus
  47. B. M. Slomovitz, T. W. Burke, P. J. Eifel et al., “Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases,” Gynecologic Oncology, vol. 91, no. 3, pp. 463–469, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. P. S. Craighead, K. Sait, G. C. Stuart et al., “Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994,” Gynecologic Oncology, vol. 77, no. 2, pp. 248–253, 2000. View at Publisher · View at Google Scholar
  49. M. G. Kelly, D. O'Malley, P. Hui et al., “Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation,” Gynecologic Oncology, vol. 95, no. 3, pp. 469–473, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. N. E. Tchabo, S. McCloskey, T. L. Mashtare et al., “Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006,” Gynecologic Oncology, vol. 115, no. 2, pp. 249–256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Hui, M. Kelly, D. M. O'Malley, F. Tavassoli, and P. E. Schwartz, “Minimal uterine serous carcinoma: a clinicopathological study of 40 cases,” Modern Pathology, vol. 18, no. 1, pp. 75–82, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. A. H. Frank, P. C. Tseng, B. G. Haffty et al., “Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinoma,” Cancer, vol. 68, no. 7, pp. 1516–1519, 1991. View at Google Scholar · View at Scopus
  53. P. Lim, A. Al Kushi, B. Gilks, F. Wong, and C. Aquino-Parsons, “Early stage uterine papillary serous carcinoma of the endometrium: effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome,” Cancer, vol. 91, no. 4, pp. 752–757, 2001. View at Google Scholar · View at Scopus
  54. G. Sutton, J. H. Axelrod, B. N. Bundy et al., “Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group,” Gynecologic Oncology, vol. 100, no. 2, pp. 349–354, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. F. V. Price, “Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC),” Gynecologic Oncology, vol. 51, no. 3, pp. 383–389, 1993. View at Publisher · View at Google Scholar
  56. J. T. Chambers, S. K. Chambers, E. I. Kohorn, M. L. Carcangiu, and P. E. Schwartz, “Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide,” Gynecologic Oncology, vol. 60, no. 3, pp. 438–442, 1996. View at Publisher · View at Google Scholar · View at Scopus
  57. B. M. Sood, J. Jones, S. Gupta et al., “Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma,” International Journal of Radiation Oncology Biology Physics, vol. 57, no. 1, pp. 208–216, 2003. View at Publisher · View at Google Scholar · View at Scopus